B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
about
Prognostic significance of the TREK-1 K2P potassium channels in prostate cancerMicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.Therapy to target renal cell carcinoma using 131I-labeled B7-H3 monoclonal antibodyOverexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.Checkpoint inhibitors in bladder and renal cancers: results and perspectives.The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature.miR-206 inhibits renal cell cancer growth by targeting GAK.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.Liquid biopsy: a step forward towards precision medicine in urologic malignancies.New B7 Family Checkpoints in Human Cancers.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma.B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma
P2860
Q36210906-1A5BBB7B-3366-4743-8E17-86493E981F6CQ36931346-AD17197C-3271-4DAD-8467-9AD82E18D6BEQ37269482-0F68580F-11E0-44AC-80BE-4DCCD6F7FEC5Q37697212-D7C414D9-6449-4AB0-BCC0-46241095E130Q38643514-E09EA9F9-8D27-4300-8D30-3995AB5540E4Q38666253-9687F6C5-BF4C-4701-9AED-385CD72B8102Q38708078-7B907D56-902D-45F9-A396-2EC49B9949F3Q38727341-07768117-4249-4FC1-B478-4BAB3FE12F1BQ39160982-2FEAEEA2-2FDB-4722-8AD9-07879B1AA429Q39243268-6B35C4A9-C0E9-4874-BF5C-F09528A1495AQ39416195-6F37BF9B-664C-4AC5-9502-88224E18C8F6Q41809391-1D0D319E-C336-4C09-9F92-36E03E91F7A4Q42728633-FF29765B-0DEC-4714-A81A-6B106623140EQ47106672-FD3842DF-CFE8-41E5-A96A-657E9FCEE382Q58790295-246C1613-A6A0-4BC6-B278-0131A3F25289
P2860
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@en
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@nl
type
label
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@en
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@nl
prefLabel
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@en
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma.
@nl
P2093
P2860
P356
P1476
B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
@en
P2093
Dingwei Ye
Guohai Shi
Hailiang Zhang
Xiaojian Qin
P2860
P304
P356
10.2147/OTT.S53565
P407
P50
P577
2013-11-15T00:00:00Z